SITE Centers Corp.
SITC NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What SITE Centers Corp. does
No business description yet.
- Legal name
- SITE Centers Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001193125-26-076905
0000894315
Revenue and margins
SITE Centers Corp. had $124M of revenue in fiscal 2025, down 55.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 36.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
SITE Centers Corp. returned $356M to shareholders in fiscal 2025. The diluted share count fell 0.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably SITE Centers Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $41.8M | $20.3M | $551M | $54.6M | $119M |
| Total assets | $4.0B | $4.0B | $4.1B | $934M | $419M |
| Total liabilities | $1.9B | $2.0B | $1.9B | $417M | $84.0M |
| Shareholders' equity | $2.0B | $2.1B | $2.2B | $517M | $335M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β4.9% | β8.5% | β2.6% | β4.1% | β3.8% | β3.9% | β2.2% | 0.7% | 16.8% | 23.4% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.0B | $922M | $707M | $508M | $460M | $533M | $479M | $453M | $277M | $124M |
| Operating income | $714M | $658M | $499M | $368M | $322M | β | β | β | β | β |
| Interest expense | $218M | $189M | $141M | $84.7M | $77.6M | $76.4M | $77.7M | $82.0M | $59.5M | $15.3M |
| Pretax income | $63.0M | β$231M | $117M | $102M | $37.7M | $127M | $140M | $231M | $527M | $178M |
| Income tax | $1.8M | $12.4M | $0.9M | $0.7M | $1.1M | $1.6M | $0.8M | $2.0M | $0.8M | β$0.2M |
| Net income | $60.0M | β$242M | $114M | $101M | $35.7M | $125M | $169M | $266M | $532M | $178M |
| Net income to common | $37.6M | β$270M | $80.9M | $61.3M | $15.2M | $106M | $158M | $255M | $516M | $178M |
| Diluted EPS | $0.20 | β$1.48 | $0.43 | $0.33 | $0.08 | $0.51 | $2.94 | $4.85 | $9.77 | $3.36 |
| Diluted shares | 0.18B | 0.18B | 0.18B | 0.18B | 0.19B | 0.21B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $461M | $410M | $263M | $270M | $190M | $283M | $257M | $239M | $112M | $19.6M |
| Depreciation and amortization | $390M | $346M | $242M | $165M | $171M | $186M | $204M | $212M | $131M | $44.8M |
| Stock-based compensation | $7.8M | $11.5M | $7.5M | $9.9M | $8.8M | $13.5M | $7.2M | $7.6M | $6.8M | $1.4M |
| Share buybacks | $0.0M | $0.0M | $36.3M | $14.1M | $7.5M | $0.0M | $42.3M | $26.6M | $0.0M | $0.0M |
| Dividends paid | $294M | $306M | $281M | $181M | $98.3M | $99.5M | $120M | $121M | $128M | $356M |
| Dividends and buybacks | $294M | $306M | $318M | $195M | $106M | $99.5M | $162M | $147M | $128M | $356M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $30.4M | $92.6M | $11.1M | $16.1M | $69.7M | $41.8M | $20.3M | $551M | $54.6M | $119M |
| Intangible assets | $242M | $182M | $77.4M | $58.0M | $90.4M | $94.1M | $87.7M | $34.7M | $12.9M | $7.5M |
| Total assets | $8.2B | $7.2B | $4.2B | $4.1B | $4.1B | $4.0B | $4.0B | $4.1B | $934M | $419M |
| Total liabilities | $5.0B | $4.3B | $2.1B | $2.1B | $2.2B | $1.9B | $2.0B | $1.9B | $417M | $84.0M |
| Preferred stock | $350M | β | β | β | β | β | β | β | β | β |
| Shareholders' equity | $3.2B | $2.9B | $2.1B | $2.0B | $1.9B | $2.0B | $2.1B | $2.2B | $517M | $335M |
| Margins | ||||||||||
| Operating margin | 71.0% | 71.4% | 70.6% | 72.5% | 69.9% | β | β | β | β | β |
| EBITDA margin | 109.7% | 108.9% | 104.8% | 105.0% | 107.0% | β | β | β | β | β |
| Net margin | 6.0% | β26.2% | 16.2% | 19.8% | 7.8% | 23.4% | 35.2% | 58.7% | 191.7% | 143.8% |
| Returns | ||||||||||
| Return on equity | 1.9% | β7.9% | 4.6% | 5.0% | 1.8% | 6.3% | 8.2% | 12.5% | 39.5% | 41.8% |
| Return on assets | 0.7% | β3.1% | 2.0% | 2.4% | 0.9% | 3.1% | 4.2% | 6.6% | 21.3% | 26.3% |
| Return on tangible equity | 1.3% | β10.0% | 4.1% | 3.2% | 0.8% | 5.5% | 7.9% | 11.9% | 102.4% | 54.3% |
| Growth | ||||||||||
| Revenue growth | β | β8.4% | β23.3% | β28.2% | β9.4% | 15.8% | β10.1% | β5.6% | β38.7% | β55.4% |
| Net income growth | β | β502.7% | β | β12.0% | β64.5% | 249.8% | 35.0% | 57.5% | 100.2% | β66.6% |
| EPS growth | β | β840.0% | β | β23.3% | β75.8% | 537.5% | 476.5% | 65.0% | 101.4% | β65.6% |
| Share count change | β | 0.5% | 0.5% | β0.7% | 5.7% | 7.9% | β74.4% | β2.0% | 0.3% | β0.3% |
| Financial health | ||||||||||
| Interest coverage | 3.3x | 3.5x | 3.5x | 4.3x | 4.1x | β | β | β | β | β |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.8% | 1.2% | 1.1% | 1.9% | 1.9% | 2.5% | 1.5% | 1.7% | 2.5% | 1.1% |
| Quality scores | ||||||||||
| Accruals ratio | β4.9% | β8.5% | β2.6% | β4.1% | β3.8% | β3.9% | β2.2% | 0.7% | 16.8% | 23.4% |
Source: SEC EDGAR XBRL filings (CIK 0000894315). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.